The Akt signaling pathway activity increases as normal tissue progresses to malignant transformation, and regulates the translation of specific messenger RNAs (mRNAs) through multiple mechanisms. We have identified one such mechanism of Akt-dependent translation control as involving the lupus autoantigen La. La is an RNA-associated protein that contains multiple trafficking elements to support the interaction with RNAs in different subcellular locations. We show here that the La protein is a direct target of the serine/threonine protein kinase Akt on threonine 301, and La nuclear export in mouse glial progenitors, as well as its association with polysomes is modulated by Akt activity. Using a functional approach to determine the network of genes affected by La in the cytoplasm by microarray analysis of polysome-bound mRNAs, we found that La binds 34% of the polysome bound mRNAs and regulates the expression of a specific pool of mRNAs under KRas/Akt activation. Therefore, La appears to be an important contributor to Aktmediated translational regulation of these transcripts in murine glial cells.
Introduction
Ras and Akt signaling mediate fundamental aspects of normal growth and development in many organisms. When Ras and Akt pathways become overly active, malignant transformation of normal tissue can occur. The combined activity of these two pathways plays a pivotal role in the formation and regulation of glioblastoma, the most malignant and lethal subtype of glioma (Holland et al., 2000) . Progress in the treatment of this currently incurable cancer depends largely on an increased understanding of its biology. Akt is found to be activated in 70% of glioblastomas but also provides major survival signals to many others cancer cells. In glioblastoma, the direct response to Ras and Akt oncogenic signaling is the differential recruitment of existing messenger RNAs (mRNAs) into polysomes, resulting in altered production of growth-regulated and oncogenic proteins (Rajasekhar et al., 2003; Rajasekhar and Holland, 2004) . Thus, the most immediate and largest effect of Ras and Akt activation is on translation, followed by alterations in the transcriptome. These pathways intersect at the interface between the translation initiation factor 4E (eIF4E) and eIF4E-binding protein (4E-BP) to regulate protein synthesis at the level of translation initiation and ribosome biogenesis. However, specific components of the translational machinery regulated by Ras or Akt and directly contributing to this mechanism of gene expression are unkown.
The role of the initiation factor of translation eIF4E as a protooncogene and its sufficiency to promote metastatic progression has been demonstrated in tissue culture (Lazaris-Karatzas et al., 1990; Graff and Zimmer, 2003) and in vivo (Ruggero et al., 2004 , Wendel et al., 2004 . In addition to the components of translational machinery, RNA-binding proteins are also aberrantly expressed in tumors, including PTB (He et al., 2007) , HuR (Lopez de Silanes et al., 2003) , KH domain-containing protein, and hnRNPD among others (Gouble et al., 2002) , with a direct correlation between abnormal expression of a particular RNA-binding protein and tumor formation (CRD-BP) in breast tissue (Tessier et al., 2004) . Furthermore, many RNA-binding proteins have been reported to be direct targets of Akt, including YB-1 (Evdokimova et al., 2006) , the tumor suppressor Pdcd4 (Palamarchuk et al., 2005) , BRF1 (Benjamin et al., 2006) and KSRP (Gherzi et al., 2006) , thus linking the Akt pathway to mRNA silencing, degradation, apoptosis and the Wnt signaling pathway through the promotion of the stabilization of b-catenin mRNA, respectively.
The RNA-binding protein, La, is a phosphoprotein that acts as an RNA chaperone, and was originally identified as an autoantigen in systemic lupus erythematosus and Sjogren's syndrome (Yoo and Wolin, 1997) . La resides mostly within the nucleus where it is involved in the processing of RNA polymerase III transcripts (Fan et al., 1998; Intine et al., 2003) and acts as a retention factor for mature preexisting mRNAs (Brenet et al., 2005) . La can shuttle between the nucleus and cytoplasm upon cellular stress (Baboonian et al., 1989; Bachmann et al., 1990) . Cytoplasmic La promotes translation of a large variety of viral (Meerovitch et al., 1993; Chang et al., 1994) and cellular RNA (Kim et al., 2001; Holcik et al., 2003) through internal ribosome entry sites because of its modular structure (Trotta et al., 2003; Alfano et al., 2004; Dong et al., 2004) . The fact that La is also able to facilitate translation of other mRNAs containing a 5 0 -UTR terminal oligopyrimidine element encoding ribosomal and translation relatedproteins (Crosio et al., 2000; Meyuhas, 2000; Cardinali et al., 2003) suggests a key role for La in mRNA translational regulation and makes La a potential candidate for the recruitment of oncogenic mRNAs to polysomes.
In our efforts to determine how La activities might be regulated by the KRas/Akt pathway during translation, we identified La as a new target of the serine/threonine protein kinase Akt. Our results uncover a previously unknown function of La protein as a component of translation regulation during KRas/Akt oncogenic signaling.
Results

External growth stimuli regulate La protein levels through Akt activation
The translation of specific mRNAs is elevated in response to growth factors, hormones and mitogens (Rajasekhar and Holland, 2004) . As these signals exert their effects in part by phosphorylating many proteins involved in translational regulation (Gingras et al., 1999) , we tested whether the level and phosphorylation status of La might be altered in response to proliferative stimuli. Using RCAS/tva (the receptor for the avian retroviral vector RCAS) system, we generated mouse glial progenitors with independently regulatable activity of Ras and Akt signaling pathways. The RCAS/tva system achieves cell-type-specific gene transfer using avian ALV-based RCAS retroviral vectors (Holland et al., 1998) . Briefly, primary brain cultures were generated from the mice-transgenic expressing tva and from the nestin promoter (Ntva cells). These Ntva primary cultures support RCAS-mediated cell-typespecific gene transfer to nestin-expressing glial progenitor cells. We achieved chronic activation of the Ras or Akt signaling pathways in Ntva cells by infecting with RCAS vectors encoding either a constitutively active Kras (Ntva/R) or a constitutively active Akt (Ntva/A). The Ntva cells were also infected with both RCAS-Ras and RCAS-Akt (Ntva/RA) for combined activation, or with RCAS-PDGFB (platelet-derived growth factor-B; Ntva/P) as previously described (Dai et al., 2001) . Glial progenitors infected with an RCAS vector encoding LacZ (Ntva/Z) were used as a control as they display low basal activity of the major proliferative pathways. The signaling pathways in these cells as well as their drug sensitivity has been found similar to human glioma cell lines (U373 and U87) in a previous study from our group suggesting that this murine system is sufficiently Figure 1 External growth stimuli regulate La protein levels through Akt activation. (a) Protein extract of nestin-expressing glial progenitors infected with activated Ras (R), platelet-derived growth factor (PDGF; P), Akt (A), both Ras and Akt (RA), or LacZ (Z) as a control were analysed by western blot (WB). (b and c) Ntva/Z cells were grown to 80% confluence, serum starved for 24 h, and then either stimulated ( þ ) or not (À) with 50 ng/ml insulin growth factor (IGF)-I, 20% dialysed fetal bovine serum (FBS), 20 ng/ml PDGFB for 2 h (b) or treated with 45 mM perifosine, 20 ng/ml rapamycin, 100 mM LY294002 or 50 mM U0126 for 2 h before stimulation with PDGFB ( þ ). (c) The protein extracts were analysed by WB using indicated antibodies. Actin was used as a control in all WB.
Akt-dependent La polysomes association F Brenet et al similar to human to be used as a model system (Rajasekhar et al., 2003) . The highest level of La was found in Ntva/RA and Ntva/P cells compared with control Ntva/Z, Ntva/A, or Ntva/R cells ( Figure 1a) .
Next, we determined the response of La levels to transient alteration in the PI3K pathway. The strongest induction of Akt and La expression was achieved by using PDGFB, and to a lesser extent by insulin and serum treatment (Figure 1b) . To distinguish the relative contribution of PI3K-Akt or mitogen-activated protein kinase pathways to this effect, we used pharmacological inhibitors, such as the MEK-specific inhibitor, U0126; the PI3 kinase inhibitors, such as LY294002; the Akt signaling inhibitor perifosine, as well as the mammalian target of rapamycin (mTOR) inhibitor rapamycin. We treated cells for 2 h before stimulation and measured the activity of Akt/Ras pathways by western blot. The potency and specificity of these inhibitors in Ntva/RA cells was demonstrated by measuring the activity of signaling components in either Ras or the Akt pathways ( Figure 1c ). U0126 specifically inhibited phosphorylation of Erk1/2 to the basal levels, although having no effect on phospho-Akt and its downstream targets (Figure 1c ), whereas LY294002 slightly reduced Akt, mTOR and S6 ribosomal protein phosphorylation to a similar extent as rapamycin. Treatment with perifosine caused a significant inhibition of both Akt and S6 ribosomal protein after 2 h of treatment, whereas having less effect on ERK1/2, consistent with previous studies (Momota et al., 2005) . The largest increase in La levels was observed on PDGFB treatment and was completely reversed to the basal level by perifosine and LY294002 treatment; U0126 treatment had a lesser effect and rapamycin treatment did not affect the level of La protein. These results suggest that La levels depend on growth conditions and are regulated by the PI3K-Akt pathway, with some input from mitogen-activated protein kinase pathway as well.
Akt phosphorylates La protein in vitro La can be phosphorylated on its C-terminus in vitro by several kinases such as casein kinase II, protein kinase A or protein kinase C (Broekhuis et al., 2000) . As La is known to be a phosphoprotein, we determined whether the phosphorylation state of La was regulated by the PI3K-Akt pathway. We treated mouse glial progenitors with various growth factors or inhibitors described above while simultaneously labeling with [ 32 P]orthophosphate. Phosphorylated La was then immunoprecipitated and detected by autoradiography. Phosphorylation of La was significantly elevated (six fold) by PDGFB, and to a lesser extent by insulin and 20% fetal bovine serum (threefold; Figure 2a ). We also found that La phosphorylation was strongly inhibited by perifosine and LY294002, but not by rapamycin and less by U0126 (Figure 2b ). Akt phosphorylation was inhibited by perifosine and LY294002 to a degree that parallels the decrease in La phosphorylation. These results suggest that phosphorylation of La is regulated through the PI3K-Akt pathway, but not by the mTOR or the mitogenactivated protein kinase pathways.
A search for potential phosphorylation motifs in the La protein sequence using a scanning prediction tool (http://scansite.mit.edu/) highlighted Ser219 and Thr301 as potentially phosphorylated by Akt (Figure 2c ), although neither site was a perfect match to the consensus site. To determine whether La can be a direct substrate of Akt, we performed a series of in vitro phosphorylation experiments. First, we determined the ability of Akt to phosphorylate La using a recombinant wild-type La protein tagged with growth factor protein (GFP-La wt ) and commercially available inactive and activated forms of Akt. GFP-La wt and its variants were generated as described in Materials and methods, and recombinant proteins were purified from a total protein lysate using magnetic anti-GFP microbeads. Reactions were carried out in the presence of [ 32 P]ATP, and phosphorylation was detected by autoradiography. Akt specifically phosphorylated GFP-La wt , but not GFP alone ( Figure 2c ). A C-terminal fragment of La containing the putative phosphorylation site, T301 (but not an N-terminal construct missing this site), was efficiently phosphorylated by activated Akt. Next, we mutated the two predicted phosphorylation sites to alanine and used the resulting GPF-tagged mutant proteins, GFP-La S219A and GFP-La T301A in this assay. Although the GFP-La S219A mutant was phosphorylated similar to the wild type (lane 4), the T301A mutation abolished La phosphorylation, confirming T301 as an Akt phosphorylation site in vitro.
To determine whether Akt phosphorylates La in living cells, we transiently transfected glial progenitors with constructs expressing GFP-fused wild-type La (GFP-La wt ) or S219A (GFP-La
S219A
) or T301A (GFPLa T301A ) mutants and metabolically labeled them with [ 32 P]orthophosphate. Stimulation of these cells with PDGFB increased phosphorylation of the GFP-La wt and the GFP-La S219A mutant, but had no effect on the GFP-La T301A mutant ( Figure 2d ). The T301A mutation did not block La phosphorylation entirely, suggesting that other kinases may additionally phosphorylate La on other sites. Taken together, these data demonstrate that growth factor stimulation and PI3K/Akt pathway activation induce phosphorylation of La by Akt on T301 in mouse glial progenitors.
The PDGFB-induced nuclear export of La is Akt-dependent La contains both nuclear localization and nuclear export signals, suggesting its potential to shuttle between nuclear and cytoplasmic compartments. Akt regulate trafficking of multiple proteins through direct phosphorylation; therefore, we determined whether Akt-induced La phosphorylation would affect its subcellular distribution. We used Ntva/Z cells with low Akt activity and examined La subcellular localization following PI3K/Akt activation. PDGFB stimulation of serum-starved cells changed the steady-state distribution of La protein from the nucleus to the cytoplasm within 20 min (Figure 3) . By contrast, pretreatment Akt-dependent La polysomes association F Brenet et al prevent and mimic phosphorylation of the residue, respectively. We transfected the GFP-La wt , GFP-La T301A or GFP-La T301E constructs into Ntva/Z cells and assessed the effect of PI3K/Akt activation on La subcellular localization (Figure 4a) . In these cells, the wild-type La protein was mostly nuclear and became cytoplasmic within 20 min of PDGFB stimulation. By contrast, the T301A La mutant showed reduced PDGFB-induced translocation, whereas the phosphomimetic T301E La mutant was nuclear in the absence of PDGFB stimula- Akt-dependent La polysomes association F Brenet et al tion, but was exported into the cytoplasm during PDGFB-induced signaling. These data suggest that, although Akt-phosphorylation of La is necessary, it may be insufficient to induce the export of the protein out of the nucleus. As perifosine treatment appear to have an effect on cellular morphology, reducing cytosolic protusions, which could affect conclusions regarding localization, we tested the effect of perifosine treatment on the localization of the mutant T301E. T301E that mimics phosphorylation was resistant to perifosine for its localization confirming that it is indeed phosphorylated in an perifosine-sensitive manner (Figure 4, vi) .
To further confirm the importance of Akt in the shuttling of La, we repeated the above experiment using Ntva/A glial progenitors expressing constitutively active Akt (Figure 4b ). Although the wild type form of La and T301E mutant were predominantly cytoplasmic, when these cells were exposed to serum, the T301A La mutant remained exclusively nuclear. This confirms that the phosphorylation of this site is required for nuclear export of La. Taken together, these findings indicate that growth factor stimulation through the endogenous PI3K/Akt pathway induces the phosphorylation of La at T301, an event necessary, but not sufficient to La is associated with translating polysomes upon Akt activation In X. laevis embryos, La is associated with terminal oligopyrimidine tracts of mRNAs in actively translating polysomes (Cardinali et al. 2003) . To test whether La is associated with polysomes in the cytoplasm of glial cells and whether this association is Akt-dependent, we fractionated polysomes by sucrose gradient centrifugation and compared the distribution of La in polysomal profiles of Ntva/Z and Ntva/RA cells. The fractionation led to a postpolysomal preparation (nonpolysomal) and a polysomal preparation (Figure 5a, top panel) . In Ntva/Z cells, La was detected exclusively in the postpolysomal fraction (Figure 5a ). By contrast, in Ntva/RA cells, La was detected throughout the polysomal region of the gradient (Figure 5b) . Treatment of the lysates with 30 mM EDTA (ethylenediaminetetraacetic acid) to disrupt polyribosome-shifted La complexes into the postpolysomal region ( Figure 5b) . As a control, we also showed that the distribution of the large ribosomal subunit protein L7 was the same in both cell types. Finally, we treated the Ntva/RA lysates with RNase A and showed that La was no longer associated with polysome-sized particles by sedimentation (data not shown).
We confirmed the importance of phosphorylation of La on T301 in its association with polysomes by transfecting Ntva/RA cells with GFP-La wt or GFPLa T301A mutant constructs and followed La throughout the polysomal profile. Cells expressing GFP-La wt presented the same postpolysomal and polysomal distribution as the endogenous La, whereas cells expressing the La T301A mutant exhibited an exclusively postpolysomal La localization (Figure 5c ).
Microarray analysis identifies Akt-induced and La-associated polysome-bound mRNAs
The mRNAs that La chaperones to polysomes are likely to be a clue to the effect of La in oncogenesis. Therefore, we utilized affymetrix murine microarray chips to identify polysome-and La-associated mRNAs. We performed immunoprecipitation of La/mRNA complexes with an anti-La antibody from the cytoplasmic extracts of Ntva/RA cells and analysed the microarray expression profile of the immunoprecipated mRNAs (Supplementary Table S1 ; Tenenbaum et al., 2000) .
First, we compared La-associated mRNAs with total cellular RNAs to identify mRNAs that preferentially bind La in these cells (Supplementary Table S1 ; La-associated mRNAs). Of the 22,626 total mRNAs detectable by the MOE-430A microarray, 1042 mRNAs (4.6%), were more than threefold enriched in the Labound population and had a false discovery rate less than 0.01 relative to total cellular mRNAs (Figure 6a ). Many of these La-bound transcripts encode proteins belonging to the distinct regulatory pathways. These include 10 members of mitogen-activated protein kinase cascade, five components of cyclin and cyclin-dependent kinases, 12 members of the Ras oncogene family, four members of Bcl-2-related family, a number of proteins involved in translational control (ribosomal proteins and initiation factors of translation) and others. (Supplementary Table S1 ). We also found La protein bound to transcripts coding for growth factors, recep- Akt-dependent La polysomes association F Brenet et al tors and related proteins, including PDGFA, tumor necrosis factor superfamily member 12, VEGF-B (vascular endothelial growth factor B), fibroblast growth factor receptor-like 1 and fibroblast growth factor receptor-activating protein 1. Next, we generated a list of mRNAs preferentially associated with polysomes by comparing array analysis of mRNAs associated to polysomes (isolated by centrifugation, Rajasekhar et al. 2003) to total cellular mRNAs. A total of 1370 mRNAs (approximately 6%) were preferentially loaded on polysomes (ratio of greater than threefold with a false discovery rate less than 0.01) in Ntva/RA cells (Supplementary Table S2 ; polysomebound RNAs). The overlap of the two populations showed that 472 (B34%; P-value from the Fisher's exact test of overlap o10 À300 ) of polysome-bound mRNAs were preferentially La bound as well (Venn diagram, Figure 6a , Supplementary Table S3) , suggesting a role of La in the redistribution of a pool of mRNAs to polysomes under oncogenic signaling.
As false positives are a significant contaminants of array analysis, we applied two sequential high-stringency filters to the above 472 genes found to be regulated by La and loaded on polysomes. Thus, the first filter determined how many of the 472 transcripts identified as La-and polysome bound, are maintained in polysomes because of Akt activity by asking for reversal of polysome binding with 2 h of perifosine treatment. We found that of the 472 mRNAs identified as both Laand polysome bound, 306 (B65%) were reversed by Akt signaling blockade with a false discovery rate less than 0.05 (Supplementary Table S4 ). By contrast, there was a minimal effect on the total cellular RNA implying minimal transcriptional changes over this period, consistent with previous studies.
We then applied a second filter to the 306 transcripts listed above to determine whether the Akt-dependent recruitment of these RNAs to polysomes was also dependent on La protein. Reduction in La expression in Ntva/RA cells following treament with an siRNA (Small interfering RNA) against La mRNA resulted in 266 (B87%) of the 306 transcripts showing reduced polysomes association (Figure 6a ). The majority of mRNAs identified as La bound, Akt regulated and Table S5 ). A search for biological themes associated with these transcripts revealed that many of them have already been identified in cancer biology or found to be the components of pathways critical to oncogenesis. These include mRNAs encoding VEGF, PDGFA, various cell signaling proteins (kinases, phosphatases), transcription factors and proteins involved in proliferation and growth (cyclin G2, Jun protooncogene nuclear protein among others), mRNA processing, protein degradation and modification metabolic enzymes (Figure 6b) .
To verify the identities of selected candidate mRNAs in La complexes, we performed semiquantitative reverse transcriptase PCR analysis of RNAs preparations derived from Ntva-RA cells challenged with perifosine or not. Having established that phosphorylation by Akt may trigger La protein association with mRNAs, we chose to analyze La-bound mRNAs in order to determine whether association of translationally active transcripts with La protein might be affected by Akt activation. RNAs were thus recovered directly from total fractions or after IP with anti-La antibody. For these analyzes, we chose several representative growthand stress-related mRNAs, such as PDGF-A, Cyclin D2, Ornithine decarboxylase, Pax3, Pdpk1, Map3k3, Rab13, VEGF-B, Sox 4, and Bcl-2 like 11 (Figure 6d ). Since GAPDH was not found in complex with La protein, we used it to control for unspecific binding. Not surprisingly, considering the short time of treatment and the semi-quantitative nature of reverse transcriptase (RT)-PCR, the levels of each tested transcripts recovered from total RNA populations were not significantly altered in response to perifosine (Figure 6d, second gel) . However, binding of certain transcripts to La was dramatically changed by the above treatment. For example, Pax3 or Rab13 mRNA, which were undetectable in total RNA preparations, were highly enriched in the pool of Labound transcripts (Figure 6d, lane 6, 9) . Similarly, levels of almost all transcripts tested were markedly elevated in La complexes compared with total RNA preparations ( Figure 6d , lane 2-10). Treatment with perifosine reduced association of La protein with many transcripts (Figure 6d ). GAPDH (glyceraldehyde-3-phosphate dehydrogenase) mRNA, used as a control, was readily detected in the preparation of total RNAs, but not in the pool of La-bound transcripts (lane 12). For unclear reason, we failed to detect VEGB-B mRNA in the complex with La, probably because of the highly secondary structured nature of the RNA or because anti-La antibody used impeded the interaction of La with the messenger. None of the mRNAs tested was detected when immunoglobulin-G were used as bait for RNA isolation (Figure 6d , bottom gel) further indicating the selectivity of La binding to certain mRNA species.
Discussion
Ras and Akt pathway activation rapidly alters the pattern of existing mRNAs recruited to polysomes (Rajasekhar et al., 2003) . The PI3K-Akt signaling cascade leads to the phosphorylation and inactivation of translational repressors, the eIF4E-binding proteins and induction of mTOR activity (Gingras et al., 1998) . Here, we identify mouse La protein as a direct target of Akt. Unlike the case of YB-1, where Akt phosphorylation resulted in silencing of the YB-1-bound RNAs without impact on the localization of the protein (Evdokimova et al., 2006) , there is Akt-dependent export of La to the cytoplasm and association of a specific subset of La-bound mRNAs to polysomes. In glioma in vivo, La is cytoplasmic in cells throughout the tumor, suggesting a potential role of La in partly mediating the oncogenic effects of Akt by enhancing the translation of specific mRNAs, and thereby modifying the oncoproteome.
The target site sequence around T301 is not a perfect match to the widely cited consensus target site for Akt, R-x-R-x-x-S/T (Manning and Cantley, 2002) . The second R is a K in La proteins. It is known for other protein kinases that require charged side chains in their substrate target sites that the inclusion of additional amino acids of the same charge in the target site sequence enhances substrate activity, whereas amino acids of the opposite charge inhibit substrate activity. This suggests that although the mouse La sequence does not match the R-x-R-x-x-S/T consensus site, it is a good substrate in part because of the effect of the second K in the target sequence. Furthermore, the R-x-K-x-x-S/T sequence has also been shown to be an autophosphorylation consensus site in human Akt3 and chicken Akt1 (Li et al., 2006) .
Our data show that phosphorylation on T301 leads to nuclear export of La. Previous studies (Bayfield et al., 2007) indicate that alterations of the nuclear retention element structure promote nuclear export by unmasking a nuclear export sequence. As the nuclear retention element comprises amino acids 316-332, it resides adjacent to T301, and it seems reasonable to expect that phosphorylation of T301A would alter the nuclear retention element structure to unmask the export element.
The polyribosome association of La in cell lines has suggested La's involvement in translational regulation (Meerovitch et al., 1989 (Meerovitch et al., , 1993 . Our data furthermore present evidence that phosphorylation of La T301 is essential for polyribosome association in glial progenitor cells. In this study, we specifically used the alkylphospholipids perifosine as an inhibitor of the Akt pathway, because it is currently in clinical trials of several tumor types, including gliomas (Crul et al., 2002) . It is worth noting that the regulation of translational efficiencies of many critical mRNAs will be one of the molecular outcomes of therapy targeting Akt activity in gliomas and probably other tumor types as well.
Our array analysis of the mRNAs coimmunoprecipitated with the La allowed identification of a large pool of target mRNAs regulated by La upon Akt signaling. Although the mechanisms that achieve the specificity defining the subset of mRNAs affected by La are still unknown, it is clear that La does exhibit selectivity toward specific mRNAs. The total effect of these changes in the proteome will very likely impact the biological functions associated with the oncogenic phenotype.
Altogether, the results presented here define a signaling pathway affecting La protein activity and resulting in the orchestrated regulation of two key physiological steps in cancer, shuttling between nucleus/cytoplasm and translation. The presence of phosphorylated La bound to a specific subset of transcript would turn these molecules into a better template for translation. Furthermore, there are many known RNA-binding proteins that could contribute to the regulation of translation in specific mRNA subsets. However, the fact that 34% of the polysome-bound mRNAs were also La bound in murine glial cells, suggests that La could be an important contributor to Aktmediated translational regulation of these transcripts and play an important role in the regulation of translation in the normal and neoplastic brain.
Materials and methods
Cell culture
Nestin tva transgenic glial progenitors infected with RCASLacZ (Ntva/Z), RCAS-K-Ras (Ntva/Ras), RCAS-KRas þ Akt/HA (Ntva/RA) and RCAS-PDGF-B (Ntva/P) were generated by retroviral infection and cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 1% penicillin/streptomycin and 1% L-glutamate at 37 1C. For orthophosphate labeling, cells were treated for 2 h with different drugs in the presence of 0.1 mCi/ml of [ 32 P]orthophosphate (3000 mCi/mmol; Amersham Biosciences Piscataway, NY, USA). The cells were lyzed, and utilized for immunoprecipitation. For siRNA experiments, siRNA against La was designed using Qiagen HP-guaranteed siRNA service. Cells were grown to 20% confluence and transfected the next day using HiPerFect Transfection Reagent as per manufacturer's recommendations (Qiagen, Valencia, CA, USA). At 48-h post-transfection, cells were harvested for western blotting and polysome fractionation.
Constructs
Growth factor protein-La, GFP-LaNterm and GFP-LaCterm constructs were generated by cloning the murine La sequence into pcDNA3.1/NT-GFP-TOPO (Invitrogen, Carlsbad, CA, USA) using primers described in Supplementary Table S7 . S219A, T301A and T301E La point mutants were created by site-directed mutagenesis using the GeneTailor Site-Directed Mutagenesis kit (Invitrogen) with GFP-La as a template and primers described in Supplementary Table S7. GFP protein purification Glial progenitors were transfected with GFP-La constructs using Fugene 6 (Roche Applied Science, Indianapolis, IN, USA) following the manufacturer's instructions. After 24 h, cells were lysed and GFP-tagged proteins were purified with magnetic mMACS Epitope Tag Protein Isolation kit (MACS Miltenyi Biotec, Germany), following the manufacturer's recommendations (nondenaturing protocol). Contructs were also used in translocation studies as described in Supplementary informations S8.
Western blot
Proteins were prepared by lysis of cell pellets in RIPA buffer (Santa Cruz Biotechnology, Santa Cruz, CA, USA) supplemented with 30 mmol/l sodium fluoride, 1 mmol/l sodium vanadate, 0.5 mmol/l phenylmethylsulfonyl fluoride and protease inhibitor cocktail tablets (Roche, Indianapolis, IN, USA). Samples were separated by 10% sodium dodecyl sulfate-PAGE gel, and transferred onto polyvinylidene difluoride membrane (Millipore, Bedford, MA, USA). Membranes were blocked with 5% nonfat milk in phosphatebuffred saline, 0.1% Tween 20. Primary and secondary antibodies were diluted in the same solution. Primary antibodies against Akt (9272), P-Akt (9271), S6 kinase (9202), P-S6 K (9205), Erk 1/2 (9102), P-Erk 1/2 (9101), mTOR (2972), P-mTOR (2974) and P-eIF4E (9741) from Cell Signaling (Beverly, MA, USA) were used at 1:1,000 dilution, anti-Actin (I-19; Santa Cruz Biotechnology, Santa Cruz, CA, USA) was used at 1:500 dilution, and anti-La (6741) (Abnova, Taiwan) was used at 1:50. Secondary peroxidase-conjugated antirabbit antibody (Amersham Biosciences, Piscataway, NJ, USA) and antimouse antibody (Roche) were used at 1:1000 dilution. Signal was visualized using enhanced chemiluminescence (Amersham Biosciences). Signal intensities were quantified using ImageJ 1.38X (Wayne Rasband, National Institutes of Health (NIH), MD, USA).
In vitro Akt kinase assay Recombinant La protein or its derivatives (1 mg of each) were incubated with the activated or inactive forms of Akt (0.5 mg) in a 25-ml reaction mixture containing 40 mM MOPS, pH7, 1 mM EDTA, 2 mM ATP, and 10 mCi [g 32 P]ATP (3000 Ci/mmol; Perkin Elmer, Waltham, MA, USA). After incubation for 20 min at 37 1C, reactions were stopped by adding 4 Â Laemmli buffer, boiled and resolved on a 10% sodium dodecyl sulfate-PAGE. Gel was dried under vacuum and analysed by autoradiography.
Polyribosome profiling
Polysomes were purified from N-tva/Z and N-tva/RA cells following the protocol described in Supplementary informations S8.
RNA extraction for Affymetrix GeneChip technology
La protein bound-RNA were coimmunoprecipitated from cytoplasmic extract using a method by Holcik et al. (2003) with some modifications (Supplementary informations S8) .
Reverse transcriptase-PCR assays
The reverse transcription was performed using the Invitrogen Superscript III kit and 2 mg of total RNA or 2 mg of RNAs recovered from La immunocomplexes. All primers sets for PCR are shown on Supplementary Table S7 . In all, 25-ml PCR reaction were performed using Hi-Fidelity Taq polymerase system from Roche under the following conditions: initial denaturation at 94 1C for 5 min followed by 30 cycles with one cycle consisting of 1 min at 94 1C, 1 min at 60 1C and 2 min at 72 1C.
